pharmaglobenews, Author at Pharma Globenewswire

Myelofibrosis Market Set to Reach USD 5.6 Billion by 2034 Across 7MM Healthcare Economies

The Myelofibrosis market across the seven major markets (7MM), including the United States, EU4, the United Kingdom, and Japan, is anticipated to witness substantial expansion during the forecast period. The market is projected to grow from nearly USD 2,602 million in 2025

13 May 2026

Uncategorised

Medical Marijuana Market Poised for Strong Growth Through 2032 | DelveInsight

DelveInsight’s “Medical Marijuana Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Medical Marijuana, historical and forecasted epidemiology as well as the Medical Marijuana market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom)

12 May 2026

Uncategorised

Graft Versus Host Disease Market Set to Surpass USD 2.1 Billion in 2025 Driven by Emerging Therapies and Rising HSCT Procedures Across Seven Major Markets

Graft Versus Host Disease Market Overview The Graft Versus Host Disease market continues to witness robust growth across the 7MM (the US, EU4, the UK, and Japan). According to DelveInsight’s analysis, the GvHD market was valued at approximately USD 2.1 billion in

12 May 2026

Market Insights·News·Reports

Hidradenitis Suppurativa Market Forecast 2036

Hidradenitis Suppurativa Market Size was nearly USD 1.5 billion in the 7MM in 2024. The largest market size was captured by the US. Management involves antibiotics, surgery, and biologics like HUMIRA and COSENTYX. BIMZELX, approved in Europe, is under US FDA review.

11 May 2026

Uncategorised

Prefilled Syringes Market Insights, Market Trends, and Market Forecast 2032

DelveInsight’s “Prefilled Syringes Market Insights, Market Trends, and Market Forecast – 2032” report delivers an in-depth analysis of the rapidly evolving prefilled syringes market. The report offers a comprehensive overview of market dynamics, technological advancements, competitive intelligence, and growth drivers shaping the

11 May 2026

Uncategorised

Polycythemia Vera Market Size, Share, Growth Trends, Therapies, and Emerging Pipeline Outlook 2026-2036

Polycythemia Vera Market The Polycythemia Vera market is witnessing significant transformation driven by evolving therapeutic innovations, expanding diagnosed populations, and a growing pipeline of targeted agents. The total Polycythemia Vera market size across the 7 Major Markets (7MM) is approximately ~USD 2,000

11 May 2026

Uncategorised

Dravet Syndrome Market Insights, Epidemiology and Market Forecast 2036

DelveInsight’s “Dravet Syndrome Market Insights, Epidemiology, and Market Forecast-2036” report delivers an in-depth understanding of the Dravet Syndrome, historical and forecasted epidemiology as well as the Dravet Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) and the United

8 May 2026

Uncategorised

Non-Small Cell Lung Cancer Market Set to Surpass USD 33 Billion Driven by Breakthrough Therapies, Pipeline Innovation, and Rising Global Incidence Through 2036

Non-Small Cell Lung Cancer Market Summary According to DelveInsight’s analysis, the Non-Small Cell Lung Cancer market size was found to be approximately USD 33 billion in the leading markets – the United States, the EU4 (Germany, France, Italy, and Spain), the United

8 May 2026

Clinical Trials·Drug Launches & Approvals·News·Reports

PROTAC Market Forecast Signals Robust Growth Through 2034

The PROTAC market is witnessing substantial momentum owing to the growing demand for next-generation targeted therapeutics capable of degrading disease-causing proteins previously considered “undruggable.” Rising investments in oncology research, rapid advances in targeted protein degradation (TPD) technologies, and increasing clinical success of

7 May 2026

Clinical Trials·Drug Launches & Approvals·News·Reports

Orforglipron Market Set for Significant Expansion Through 2034

The global metabolic disease treatment landscape is rapidly evolving, and one investigational therapy attracting substantial industry attention is orforglipron, Eli Lilly and Company’s once-daily oral GLP-1 receptor agonist. With strong late-stage clinical data, expanding therapeutic applications, and increasing demand for convenient obesity

7 May 2026

pharmaglobenews

Myelofibrosis Market Set to Reach USD 5.6 Billion by 2034 Across 7MM Healthcare Economies

Medical Marijuana Market Poised for Strong Growth Through 2032 | DelveInsight

Graft Versus Host Disease Market Set to Surpass USD 2.1 Billion in 2025 Driven by Emerging Therapies and Rising HSCT Procedures Across Seven Major Markets

Hidradenitis Suppurativa Market Forecast 2036

Prefilled Syringes Market Insights, Market Trends, and Market Forecast 2032

Polycythemia Vera Market Size, Share, Growth Trends, Therapies, and Emerging Pipeline Outlook 2026-2036

Dravet Syndrome Market Insights, Epidemiology and Market Forecast 2036

Non-Small Cell Lung Cancer Market Set to Surpass USD 33 Billion Driven by Breakthrough Therapies, Pipeline Innovation, and Rising Global Incidence Through 2036

PROTAC Market Forecast Signals Robust Growth Through 2034

Orforglipron Market Set for Significant Expansion Through 2034

Recent Posts

Banner

Newsletter

Authors